Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Realgar-Indigo Naturalis Formula and Radiotherapy in Childhood Rhabdomyosarcoma
NCT05708391Phase 2Unknown
- Sponsor
- Xinhua Hospital
- Start
- Jan 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules, Drug Delivery Systems
01
Overview
A Phase 2 trial of Compound Huangdai Tablet in rhabdomyosarcoma (RMS), sponsored by Xinhua Hospital. Status: unknown.
02
Drugs
Compound Huangdai Tablet
03
Conditions
rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT05708391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05708391.